You just read:

Orexigen Therapeutics Announces Commercialization and Distributorship Arrangement with Cheplapharm Arzneimittel GmbH for Mysimba™ in Germany, France and Austria

News provided by

Orexigen Therapeutics, Inc.

Aug 07, 2017, 07:10 ET